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OBJECTIVE—Vitamin D deﬁciency is thought to be a risk factor for development of type 2
diabetes, and elderly subjects at northern latitudes may therefore be at particular risk.
RESEARCH DESIGN AND METHODS—Vitamin D status was assessed from serum
concentrationsof25-hydroxyvitaminD3[25(OH)D3]in668Faroeseresidentsaged70–74years
(64% of eligible population). We determined type 2 diabetes prevalence from past medical
histories, fasting plasma concentrations of glucose, and/or glycosylated hemoglobin (HbA1c).
RESULTS—We observed 70 (11%) new type 2 diabetic subjects, whereas 88 (13%) were
previouslydiagnosed.HavingvitaminDstatus,50nmol/Ldoubledtheriskofnewlydiagnosed
type 2 diabetes after adjustment for BMI, sex, exposure to polychlorinated biphenyls, serum
triacylglyceride concentration, serum HDL concentration, smoking status, and month of blood
s a m p l i n g .F u r t h e r m o r e ,t h eH b A 1c concentration decreased at higher serum 25(OH)D3 concen-
trations independent of covariates.
CONCLUSIONS—In elderly subjects, vitamin D sufﬁciency may provide protection against
type 2 diabetes. Because the study is cross-sectional, intervention studies are needed to elucidate
whether vitamin D could be used to prevent development of type 2 diabetes.
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V
itamin D plays a pivotal role in
calcium metabolism, and vitamin D
deﬁciency may be associated with
a range of serious diseases, including
cancer, cardiovascular disease, and type 2
diabetes (1). Although the underlying
biological mechanisms are poorly under-
stood, the association of low serum
25-hydroxyvitamin D3 [25(OH)D3]c o n -
centrations with type 2 diabetes may be
mediated through effects on glucose ho-
meostasisand,inparticular,adirecteffect
of vitamin D on the b-cell function, and
thus insulin secretion (2). Several studies
have suggested that low vitamin D status
also contributes to insulin resistance (3).
Low vitamin D status is associated with
markers of impaired glucose metabolism,
such as glycosylated hemoglobin (HbA1c)
(4,5). However, most of these studies
focused on heterogeneous groups of
middle-aged subjects.
The main dietary source of vitamin D
isfattyoceanﬁsh and other marine foods,
and therefore, inadequate intake of sea-
food can result in low 25(OH)D3 concen-
trations in serum. In addition, vitamin D
is formed in humans by subcutaneous
photosynthesis from its precursor, 7-
dehydrocholesterol (1). Consequently,
in countries at high latitude, such as the
Nordic countries, very little pre–vitamin
D is formed during the winter months
(from October through March). In addi-
tion, olderageisassociatedwithadecrease
in 7-dehydrocholesterol concentration
in the human skin (6). Paired with possi-
ble reductions in sunlight exposure (7),
gastrointestinal absorption of vitamin D
may decrease (8), thereby leaving the
elderly at increased risk of vitamin D deﬁ-
ciency at an age where type 2 diabetes is
particularly common.
Given the limited available data on
therelationshipofvitaminDinsufﬁciency
with glucose homeostasis among subjects
older than 70 years, we examined serum
25(OH)D3 concentrations and various
markers of insulin resistance and glucose
metabolism in a population-based sam-
ple of elderly residents from the Faroe
Islands, a North Atlantic ﬁshing commu-
nity located at a latitude of 62°N between
Norway and Iceland.
RESEARCH DESIGN AND
METHODS—This study is part of a
larger project examining the possible
health effects of lifetime exposure to
marine food and pollutants. The Faroe
Islands constitute a unique setting at
northern latitude in which the residents
have an increased exposure to methyl-
mercury and persistent organic pollutants,
including polychlorinated biphenyls
(PCB), because of their intake of tradi-
tional marine food, including pilot whale
meat and blubber. To examine subjects
aged 70–74 years, a cohort of Faroese
m e na n dw o m e nb o r ni nt h em i d - 1 9 3 0 s
was established.
All 1,131 Faroese citizens born be-
tween 2 January 1934 and 31 August
1937receivedaletterofinvitation,713of
whom gave consent and were examined,
corresponding to a participation rate of
64%, taking into account 14 deceased
subjects. There were no differences in
regard to sex or age between participants
and nonparticipants. One subject was
excluded because of the presence of alco-
holicpancreatitis.Furthermore,sufﬁcient
serum for determination of vitamin D
status was not available from 44 subjects;
thus, 668 subjects are included in the
current study.
The participants were asked to fast
and arrive before breakfast to undergo
blood sampling and a thorough clinical
examination. BMI was calculated as
weight in kilograms divided by square of
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tothesameexaminationlocationandwere
examined by the same research nurses
and a single physician. The participants
completed current health, past medical
history, and lifestyle questionnaires, in-
cluding summary information on the fre-
quencyofﬁshdinnersduringthelastyear.
The type of ﬁsh was not speciﬁed, and
neither was the portion size.
Assessment of type 2 diabetes and
markers of glucose metabolism
Afastingcapillarybloodsamplewasused
to determine blood glucose concentra-
tion using a direct-reading glucose bio-
sensor (Precision Xceed and Abbott
Precision Xtra Plus strips; Abbott Dia-
betes Care, Copenhagen, Denmark). Be-
cause plasma has higher water content
than whole blood, the blood values were
transformed to plasma glucose con-
centration by multiplying by 1.12 as
recommendedbythemanufacturer.Fast-
ing venous blood samples were collected
by phlebotomy to perform HbA1c analy-
ses by high-pressure liquid chromatog-
raphy. All HbA1c values were given as
relative concentration, % (Diabetes Con-
trol and Complications Trial, DCCT,
aligned results). HbA1c % values were
converted to International Federation
of Clinical Chemistry and Laboratory
Medicine (IFCC) units (millimoles per
moles) by the following equation: HbA1c
(DCCT) % = 0.0915 3 HbA1c (IFCC)
mmol/mol + 2.15, provided by the labo-
ratory. EDTA-plasma was used for deter-
mination of fasting plasma insulin
concentration by time-resolved ﬂuoro-
immunoassay (AutoDelﬁa; PerkinElmer
Life and Analytical Sciences, Walla Oy,
Turku, Finland). The analytical impre-
cision of these assays was ,5%. Serum
HDL and triacylglycerides were mea-
sured by an enzymatic colorimetric reac-
tion, using a Modular P analyzer (Roche
Diagnostics, Indianapolis, IN).
Diabetic subjects were identiﬁed
from self-reported doctor’s diagnosis
and the reported use of hypoglycemic
medication; subjects were also classiﬁed
as diabetic if they reported use of diabe-
tes medication without reporting a diag-
nosis of diabetes. In participants not
previously diagnosed, type 2 diabetes
was considered to be present if the fast-
ing plasma glucose was $7.0 mmol/L
and/or if the HbA1c was $6.5% (9). In-
sulin resistance was estimated by the ho-
meostasismodelassessment(HOMA-IR)
and calculated as FPI 3 FPG / 22.5 (10),
where FPI is fasting plasma insulin and
FPGisfastingplasmaglucose.b-Celldys-
functionwasdeterminedbycalculatingthe
HOMA b-index of (20 3 FPI)/(FPG 3
3.5) (10).
Vitamin D status
Afterstorageat280°C,serum25(OH)D3
concentrations were assessed using liquid
chromatography-tandem mass spec-
trometry (LC-MS/MS) as described pre-
viously (11). The lower detection limit
was 10 nmol/L, and the coefﬁcient of vari-
ation was 9.6% at 20 nmol/L and 6.7% at
60 nmol/L.
Statistical analysis
Means (SD) were calculated for variables
showing normal distribution and median
and 25–75th percentiles (interquartile
range [IQR]) for those deviating from it.
When transformations were insufﬁcient
to obtain normal distribution, we applied
nonparametric Spearman’s correlation
coefﬁcient. When appropriate, multiple
regression analysis was carried out. Covar-
iateadjustmentincludedBMI,sex,smok-
ing status, and serum triacylglyceride
concentration.
A logistic regression model was used
to assess the association between serum
25(OH)D3 concentration and the risk of
having type 2 diabetes. Control subjects
were nondiabetic subjects, i.e., subjects
with fasting blood glucose #6 mmol/L.
Vitamin D status was used as a binary
exposure variable, i.e., dichotomized at
above (sufﬁcient) or below 50 nmol/L
(deﬁcient), and in the simple model, sex
w a su s e da sa no b l i g a t ec o v a r i a t e .I nt h e
adjusted model, additional covariates
were included, i.e., BMI, serum triacyl-
glycerides, serum HDL, PCB exposure
(sum of major PCB congeners CB-138,
CB-153, and CB-180 multiplied by 2
[12]),smoking,andmonthofbloodsam-
pling. In addition, we examined theasso-
ciation between vitamin Dstatusand risk
of having 1) newly diagnosed type 2 di-
abetes or 2) a known diagnosis of type 2
diabetes using the same models sepa-
rately. Finally, the same approach was
used to estimate the inﬂuence of ﬁsh in-
take on risk of having type 2 diabetes us-
ing subjects reporting ﬁsh intake less
than or equal to two times per week as a
reference group. In the models, we fur-
ther tested whether there wasevidence of
an interaction effect between vitamin D
status and sex and vitamin D status and
obesity. A value of P , 0.05 (two-tailed)
wastakentoindicatestatisticalsigniﬁcance.
Stata version 11.0 (Stata Corporation,
College Station, TX) was used for statis-
ticalanalyses.Thestudywasapprovedby
the Faroese Ethical Review Committee
and the U.S. institutional review board.
All participants provided written informed
consent.
RESULTS—In the current study, the
cohort consisted of 327 women and 341
menwithameanageof72.5years.Atotal
of 158 septuagenarians (24%) had type 2
diabetes, of whom 88 (13%) had been
previouslydiagnosedwiththediseaseand
70 new subjects (11%) were identiﬁed in
the current study. More than half of the
subjects had vitamin D deﬁciency, as
suggested by a serum 25(OH)D3 concen-
tration below 50 nmol/L (median, 47.6
nmol/L; IQR, 29.8–64.8 nmol/L). The
main characteristics of the current study
population are shown in Table 1.
Vitamin D deﬁciency, i.e., 25(OH)D3
,50 nmol/L, was associated with an 80%
increase in the sex-adjusted odds of
having diabetes (newly diagnosed and
previously diagnosed subjects) compared
with sufﬁcient vitamin D status (odds
ratio [OR] 1.80 [95% CI 1.23–2.64]; P =
0.002). After further adjustment for BMI,
serum triacylglycerides, serum HDL, PCB
exposure, smoking, and month of blood
sampling, the association between vita-
min D deﬁciency and type 2 diabetes re-
mained, and the OR was only marginally
affected (OR 1.67 [1.11–2.50]; P =0 . 0 1 3 ) .
In the separate analyses of previously
undiagnosed and diagnosed subjects, we
foundthatthesex-adjustedORforhaving
newly diagnosed type 2 diabetes in the
presence of vitamin D deﬁciency had
more than doubled (OR 2.25 [95% CI
1.31–3.85]; P = 0.003). After further
adjustmentforBMI,serumtriacylglycer-
ides, serum HDL, PCB exposure, smok-
ing, and month of blood sampling, the
association between vitamin D deﬁ-
ciency andnewlydiagnosedtype2diabetes
remained unchanged (OR 1.99 [1.14–
3.48]; P=0.022), whereas the adjusted
OR for pre-existing diabetes in vitamin D
deﬁciency was reduced considerably by
similar adjustment (OR 1.48; P = 0.132)
(Table 2).
We performed logistic regression
analysis on the impact of ﬁsh dinner
frequencies on the risk of type 2 diabetes.
Frequent ﬁsh intake (more than twice a
week) did not appear to alter the odds of
having type 2 diabetes (OR 1.09 [95% CI
0.64–1.86]; P = 0.744).
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Dalgård and AssociatesObesity is a risk factor for vitamin D
deﬁciency,andobesesubjectshadalower
serum 25(OH)D3 concentration than
nonobese subjects (11). Furthermore, we
have previously demonstrated in this co-
hort (11) that women have higher serum
25(OH)D3 concentration and tend to have
lower BMI. However, we did not ﬁnd any
interaction between vitamin D status and
sex (P = 0.19) or vitamin D status and obe-
sity (P = 0.84) on risk of diabetes.
Statistically signiﬁcant bivariate cor-
relations were observed between serum
25(OH)D3 concentration and several in-
dicators ofglucose metabolism,including
HbA1c (rs = 20.10; P = 0.01), fasting
plasma insulin (rs = 20.10; P =0 . 0 1 ) ,
HOMA-IR (rs = 20.10; P = 0.01), and
HOMA-B (r = 20.10; P = 0.01), whereas
t h ep l a s m ag l u c o s ec o n c e n t r a t i o n( rs =
20.01; P = 0.78) was not correlated
with 25(OH)D3 concentration. However,
b e c a u s eB M Iw a ss tr on g l ya s s o c i a t e dw i t h
vitamin D status (rs = 20.17; P ,
0.0001), the observed associations of
25(OH)D3 with fasting plasma insulin
and the HOMA indexes were substan-
tially reduced after adjustment for BMI,
sex, smokingstatus,andserum triacylglyc-
eride concentration, where none of them
were statistically signiﬁcant (Table 3).
However,HbA1cdecreasedathigherserum
25(OH)D3concentrationsafteradjustment
(b = 20.026, P = 0.026). Excluding
subjects with physician-diagnosed type 2
diabetes resulted in a smaller effect that
wasnolongersigniﬁcant,probablybecause
of reduced variation in HbA1c concentra-
tion and fewer observations (b =20.012,
P = 0.112) (Table 2). Finally, multiple re-
gression analysis did not reveal any asso-
ciation between frequency of ﬁsh dinners
and the HbA1c concentration (results not
shown).
CONCLUSIONS—In this cross-
sectional analysis of a population-based
sample of septuagenarians, we found that
the 25(OH)D3 concentration was in-
versely associated with the risk of newly
diagnosed type 2 diabetes after adjust-
ment for BMI and other established risk
factors for type 2 diabetes. Subjects with
25(OH)D3concentrationbelow50nmol/L
had the doubled risk of newly diagnosed
diabetes compared with those having
higher serum concentrations. Therefore,
our data suggest an inverse associa-
tion between the serum concentration
of 25(OH)D3 and the odds of newly diag-
nosedtype2diabetes,therebysuggestinga
protectiveroleofvitaminDagainstthede-
velopment of the disease, as suggested
previously (13). In further support of
this association, we observed an increas-
ing concentration of HbA1c with decreas-
ing 25(OH)D3 concentration, and this
association was independent of BMI, se-
rum triacylglycerides, smoking status,
and sex. Vitamin D deﬁciency showed a
much weaker OR for type 2 diabetes pre-
viously diagnosed, as could perhaps have
been anticipated, given the vigorous clin-
ical management of the disease and the
longer time interval between disease de-
velopment and the assessment of vitamin
D status. The conﬁdence interval for the
OR for the two groups of type 2 diabetes
continues to overlap considerably, and
therefore, the slight difference should not
be overinterpreted (Table 2).
HbA1c is considered an indicator of
average blood glucose concentrations
during the preceding 2 to 3 months and,
thus, a long-term marker of glucose ho-
meostasis (14). Abnormalities may be a
result of changes in insulin secretion
and insulin-stimulated uptake of glucose
in muscle and fat tissue. In vitro studies
and laboratory animal studies suggest
possible mechanisms for the effects of the
active formofvitamin D,i.e.,1,25(OH)2D,
Table 1—Baseline clinical and biochemical characteristics of 668 Faroese
septuagenarians by vitamin D status
Variable 25(OH)D ,50 nmol/L 25(OH) $50 nmol/L P value
Women, n (%) 157 (43.9) 170 (54.8) 0.005
Age (years) 72.5 (1.17) 72.4 (1.07) 0.533
Systolic blood pressure (mmHg) 151 (21.5) 148 (21.3) 0.125
Waist (cm) 103.1 (40.31) 97.2 (15.25) 0.021
Weight (kg) 83.4 (14.98) 78.1 (14.71) ,0.001
BMI (kg/m
2) 29.5 (4.75) 28.2 (4.44) ,0.001
Plasma glucose (mmol/L) 5.6 (4.8–6.1) 5.4 (4.9–6.1) 0.671
HbA1c (mmol/mol)* 42.1 (38.80–46.45) 41.0 (38.80–44.26) 0.007
Plasma insulin (pmol/L) 40 (27–61) 38 (26–53) 0.034
HOMA-IR† 9.8 (6.1–15.8) 9.0 (6.1–13.4) 0.035
HOMA-B‡ 40.7 (27.2–58.3) 39.8 (26.3–54.1) 0.042
Triacylglyceride (mmol/L) 1.5 (0.70) 1.5 (0.77) 0.657
HDL-cholesterol (mmol/L) 1.5 (0.35) 1.6 (0.37) 0.003
Total PCB‡ (mg/g lipid) 8.9 (4.8–14.7) 8.0 (4.7–13.4) 0.195
Data are means (SD) or median (25–75th percentile). *HbA1c (IFCC) mmol/mol can be converted to HbA1c
(DCCT) % by the following equation: HbA1c (DCCT) % = 0.0915 3 HbA1c (IFCC) mmol/mol + 2.15;
†HOMA-IR = (fasting plasma insulin 3 fasting plasma glucose)/22.5; ‡HOMA-% = (20 3 fasting plasma
insulin)/(fasting plasma glucose 3 3.5); ‡sum of major PCB congeners CB-138, CB-153, and CB-180
multiplied by 2 (12).
Table 2—Unadjusted and adjusted OR for type 2 diabetes in elderly Faroese aged
70–74 years
25(OH)D3 Nondiabetic*
No.
subjects
Crude OR†
(95% CI)
P
value
Adjusted OR‡
(95% CI)
P
value
All type 2 diabetic subjects
$50 nmol/L 218 55 1.00 1.00
,50 nmol/L 217 103 1.80 (1.23–2.64) 0.002 1.67 (1.11–2.50) 0.013
New subjects (b)
$50 nmol/L 218 22 1.00 1.00
,50 nmol/L 217 48 2.24 (1.31–3.86) 0.003 1.99 (1.14–3.48) 0.016
Previously known subjects (c)
$50 nmol/L 218 33 1.00 1.00
,50 nmol/L 217 55 1.57 (0.97–2.52) 0.064 1.47 (0.89–2.49) 0.132
DataareOR(95%CI)expressedforbinarytraits.*Nondiabeticsubjectshavefastingbloodglucose#6mmol/L;
†thecrudemodelisadjustedforsexandcomparestheoddsofeitheroveralltype2diabetes(alltype2diabetic
subjects), newly diagnosed type 2 diabetes (new subjects), or known type 2 diabetes in subjects (previously
knownsubjects)with25(OH)D,50nmol/Lwiththeoddsinsubjectswith25(OH)D$50nmol/L(reference
group); ‡the adjusted model includes sex, BMI, total PCB, month of blood sampling, serum triacylglyceride
concentration, serum HDL concentration, and smoking status.
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Type 2 diabetes and vitamin Donbothinsulinsecretionandinsulinsen-
sitivityasreviewedbyPittasandDawson-
Hughes (15). For instance, in mice
expressing a functionally inactive mutant
vitamin D receptor, blood glucose con-
centrations were increased and serum
insulin was reduced, as was insulin
mRNA. Pancreatic b-cells express the
vitamin D receptor and the enzyme 1-a-
hydroxylase, thus suggesting that the
active form of vitamin D has a functional
roleinthesecells.Eventhoughthecurrent
study cannot elucidate the likely mecha-
nisms involved, our results appear highly
plausible given the ﬁndings in experimen-
tal studies.
In this Faroese population of septua-
genarians, 37% are obese (11). Increased
fat mass adversely inﬂuences glucose me-
tabolism, in part by increasing insulin
resistance, and is also linked with lower
25(OH)Dconcentrationsinserum(16–18).
Therefore, we adjusted our data for BMI.
The results suggest that the negative im-
pactofvitaminDdeﬁciencyonHbA1cand
newly diagnosed type 2 diabetes risk is
independent of increased fat mass. How-
ever, because BMI does not distinguish
visceral from subcutaneous fat, some mis-
classiﬁcation of adiposity may have oc-
curred, thereby possibly causing some
uncertainty in regard to the relative inﬂu-
ence of serum 25(OH)D3 and adiposity in
diabetes development.
Our study results are comparable
with studies on vitamin D status and
type 2 diabetes in younger populations
(4,16,19,20), and the current study ex-
tends this association to 70 years of age
and older. Vitamin D status is known to
be lower in the elderly compared with the
young as the subcutaneous synthesis of
vitamin D decreases with increasing age,
due to a reduced concentration of 7-
dehydrocholesterolin the skin (1) and re-
duced absorption of oral vitamin D (8).
Hence, if the relationship between vita-
min D status and glucose homeostasis is
causal, the age-related decline in circulat-
ing concentration of 25(OH)D may aug-
menttheincreaseinriskoftype2diabetes
with age. In addition, our results suggest
that this relationship is not the result of
increased ﬁsh intake, in agreement with
the existing, somewhat equivocal evi-
dence in regard to this effect (21,22).
These differences may be a result of var-
iations in ﬁsh intake to inherent differ-
ences in the populations examined and
the study designs.
Among the strengths of our study, we
examined a general population sample
with a high prevalence of both vitamin D
deﬁciency (11) and type 2 diabetes. How-
ever,thecurrentstudyislimitedbyitscross-
sectional design and its single measurement
of vitamin D status. Nonetheless, a recent
study demonstrated excellent tracking and
that the correlation of serum 25(OH)D3
concentrations sampled 14 years apart
wassimilartothatseenforothercardiovas-
cular risk factors and that most subjects
with vitamin D deﬁciency were still deﬁ-
cient 14 years later (23).
Patients with type 2 diabetes and
elevated HbA1c concentrations are at in-
creased risk of cardiovascular disease and
total mortality compared with patients
with lower HbA1c levels (24). Thus, clin-
ical management focuses on glycemic
control, including treatment of other
modiﬁable cardiovascular risk factors to
reduce the macro- as well as microvascu-
lar complications.The inverse association
between serum 25(OH)D3 and HbA1c
suggests that vitamin D supplementation
could be considered a possible means for
supporting glycemic control of type 2
diabetes. However, some intervention
studies have shown inconclusive results
on the effect of vitamin D on HbA1c and
type 2 diabetes (15). For example, the
Women Health’s Initiative demonstrated
that daily supplementation with 10 mgo f
vitaminD3foramedianfollow-uptimeof
7 years did not reduce the risk of type 2
diabetes in postmenopausal women (25).
However, the doses used were probably
too low to bring about the necessary con-
centrations of circulating 25(OH)D3.
Therefore,furtherrandomizedclinicalin-
tervention studies are needed to elucidate
theimpactofvitaminDontheriskoftype
2d i a b e t e s .
In summary, our study extends pre-
viousﬁndingsthatahighvitaminDstatus
protects against type 2 diabetes in youn-
ger subjects to subjects older than 70
years. Likewise, our ﬁndings suggest an
inverse association between HbA1c and
25(OH)D3 also in the elderly. Because
our study has a cross-sectional design,
formalconﬁrmationrequiresintervention
studies with appropriate doses to eluci-
date whether vitamin D supplementation
could be used to counter the worldwide
epidemic of type 2 diabetes. In this re-
gard, the need to identify the necessary
daily intake of vitamin D should include
the possible effect on reducing the risk of
type 2 diabetes, with special emphasis on
the dietary needs of the elderly.
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